CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. – Eli Lilly and Company Transaction History
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. portfolio value:
$44.52M
portfolio value
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +9.41% | 11.84K shares | 3.71M | $323.35 | 137.7K |
| Q2 2022 | share | Decrease | -0.92% | -1.16K shares | 4.43M | $324.23 | 125.85K |
| Q1 2022 | share | Increase | +18.79% | 20.08K shares | 6.83M | $286.37 | 127.01K |
| Q4 2021 | share | Increase | +5.07% | 5.16K shares | 6.02M | $277.25 | 106.93K |
| Q3 2021 | share | Decrease | -1.72% | -1.78K shares | -253K | $230.3 | 101.76K |
| Q2 2021 | share | Decrease | -3.54% | -3.79K shares | 3.71M | $228.04 | 103.54K |
| Q1 2021 | share | Increase | +3.92% | 4.04K shares | 2.61M | $184.81 | 107.34K |
| Q4 2020 | share | Decrease | -2.32% | -2.45K shares | 1.78M | $166.32 | 103.3K |
| Q3 2020 | share | Increase | +5.29% | 5.31K shares | -837K | $145.05 | 105.75K |
| Q2 2020 | share | Increase | +3.24% | 3.15K shares | 2.99M | $160.1 | 100.44K |
| Q1 2020 | share | Decrease | -5.49% | -5.64K shares | -33K | $134.64 | 97.28K |
| Q4 2019 | share | Increase | +2.73% | 2.73K shares | 2.32M | $126.91 | 102.93K |
| Q3 2019 | share | Decrease | -2.04% | -2.08K shares | -127K | $107.36 | 100.2K |
| Q2 2019 | share | Decrease | -0.88% | -911 shares | -2.05M | $105.74 | 102.28K |
| Q1 2019 | share | Decrease | -32.40% | -49.45K shares | -4.27M | $123.17 | 103.19K |
| Q4 2018 | share | Decrease | -1.64% | -2.54K shares | 1.01M | $109.26 | 152.64K |
| Q3 2018 | share | Increase | +3.94% | 5.88K shares | 3.91M | $100.8 | 155.19K |
| Q2 2018 | share | Decrease | -3.02% | -4.64K shares | 829K | $79.72 | 149.30K |
| Q1 2018 | share | Increase | +45.22% | 47.93K shares | 2.95M | $71.78 | 153.95K |
| Q4 2017 | share | Increase | +6.89% | 6.83K shares | 470K | $77.79 | 106.01K |
| Q3 2017 | share | Increase | +15.81% | 13.54K shares | 1.43M | $78.29 | 99.18K |
| Q2 2017 | share | Increase | +10.53% | 8.15K shares | 531K | $74.85 | 85.64K |
| Q1 2017 | share | Increase | +1.41% | 1.07K shares | 897K | $76 | 77.48K |
| Q4 2016 | share | Increase | +4.43% | 3.24K shares | -252K | $66.02 | 76.40K |
| Q3 2016 | share | Increase | +2.04% | 1.46K shares | 225K | $71.57 | 73.16K |
| Q2 2016 | share | Increase | +3.72% | 2.56K shares | 668K | $69.79 | 71.70K |
| Q1 2016 | share | Decrease | -2.62% | -1.86K shares | -1.00M | $63.39 | 69.13K |